Charles Schwab’s Aterian ATER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,272
Closed -$13.7K 3474
2023
Q4
$13.7K Hold
3,272
﹤0.01% 3508
2023
Q3
$12.8K Hold
3,272
﹤0.01% 3548
2023
Q2
$18.1K Sell
3,272
-12,101
-79% -$94.1K ﹤0.01% 3571
2023
Q1
$159K Buy
15,373
+3,272
+27% +$43.8K ﹤0.01% 3193
2022
Q4
$112K Sell
12,101
-2,132
-15% -$26.7K ﹤0.01% 3247
2022
Q3
$212K Buy
14,233
+950
+7% +$27.6K ﹤0.01% 3162
2022
Q2
$345K Buy
13,283
+6,554
+97% +$290K ﹤0.01% 3171
2022
Q1
$197K Hold
6,729
﹤0.01% 3311
2021
Q4
$332K Buy
6,729
+1,251
+23% +$92.5K ﹤0.01% 3265
2021
Q3
$712K Buy
5,478
+1,429
+35% +$158K ﹤0.01% 3014
2021
Q2
$711K Buy
+4,049
New +$947K ﹤0.01% 3050

Other funds holding ATER

Charles Schwab's ATER Position: Q1 2024 in Review

Charles Schwab sold out of Aterian (ATER) in Q1 2024, closing a stake of 3,272 shares — an estimated $13.7K sold.

Charles Schwab first reported a position in ATER in Q2 2021 and held it in 11 quarters. The position peaked at $712K in Q3 2021. 26 funds tracked by Wall St. Rank hold ATER as of Q1 2024.

  • Charles Schwab reported no remaining Aterian position as of Q1 2024 after selling out during the quarter.
  • Charles Schwab sold 3,272 Aterian shares in Q1 2024, an estimated $13.7K.
  • Charles Schwab first reported a position in Aterian in Q2 2021 and held it in 11 quarters.
  • Charles Schwab's Aterian position peaked at $712K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Aterian as of Q1 2024.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.